A large cohort study of 461,382 GLP-1 users found that 12.7% of patients had a new nutritional deficiency diagnosis at just 6 months of therapy
Fller M, Kasinathan RS, Koka S, Huber SM, Schuler B, Vogel J, et al
Pricing is dosedependent : Lower doses (2.5 mg, 5 mg): ~ $301/month Higher doses (10 mg, 12.5 mg, 15 mg): ~ $502/month Across all dose levels, Mounjaro is more expensive than Ozempic
Follow the directions on your specific product and avoid using more than directed to try to speed up results
Even as the clinical community works to establish the long-term benefits of current GLP-1 and HRT combinations, a new generation of metabolic therapies is already moving through trials, ones that extend the biological logic of this article's central argument into territory that semaglutide and tirzepatide alone cannot reach